News
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Lindus Therapeutics, a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board of directors as a non-executive director.
.jpeg)
Why working with a university isn't always best for DTx start-ups
Our Co-Founder Michael explores the best options for DTx startups looking to start generating clinical evidence and why it might not always be best to work with academic institutions.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
A Fireside Chat with Paul Wicks: How can we make clinical research for digital therapeutics more patient-friendly?
Digital Therapeutics are still a relatively new treatment area and there is a lot to learn about conducting clinical research on them. Find out how Paul Wick's, Digital Health expert, thinks research companies can put the patients first.
Product Clinic #5: Lindus Health’s first Hackathon
In July 2022 Lindus Health commenced its first hackathon with everyone in the product team, from data science to our CTO and head of product getting involved.
.jpeg)
Why I joined Lindus Health - Hannah Swayze, Senior Trial Manager
To overcome the current barriers to clinical research; To develop innovative technology that will deliver clinical trials more efficiently; To be a part of a supportive, flexible and growing team.
%2520(1).jpeg)
Product clinic #4: One roadmap to rule all clinical trials
Our product team are agile. What does this mean? It means they move fast, customise quickly and add functionality, all without causing delays. Want to know how? Read here about the ruthless prioritisation that guides our product team.
%2520(1).jpeg)
Product Clinic #3: Embedding software engineering efficiency hacks into our clinical trial platform
Heard of dogfooding? No, not feeding your pet! The practice of using your own software to understand how it performs in the real world and catch any issues. Read about this and other software engineering hacks we are using to build better products.
How we use a decentralised trial methodology
While certain elements of clinical trial decentralisation existed before the COVID-19 pandemic, they were not commonly used across trials. The pandemic forced the research industry to adopt and deliver decentralised clinical trials, with 80% of CROs predicting that they will conduct decentralised trials by 2021-2022 (EndpointsNews Survey, May 2021). This transition was driven by the need for urgent public health trials to quickly find treatments and vaccines for COVID-19, where delivering trial procedures remotely to participants became a necessity.
%2520(2).jpeg)
Why I joined Lindus Health? Ece Kavalci, Machine Learning Engineer
Working towards a good cause. Innovative approaches to solving problems in clinical trial design. Every contribution is valued.
Product Clinic #2: Using feedback loops to build better products
Lindus Health's objective is to build better products that hit non-negotiable clinical standards and challenge outdated conventions. How do we do this? Read more here